Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures

NCT07493447 is registered in ClinicalTrials.gov with Eben Rosenthal as lead sponsor.

NCT NCT07493447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07493447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
Lead sponsor
Eben Rosenthal
Phase
Phase 1
Overall status
Recruiting
Start date
July 31, 2026
Completion date
June 30, 2031
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acoustic neuroma, brain cancer, glioblastoma, meningioma, pituitary adenoma